Health
Could Coronavirus Variants Boost Pfizer’s Vaccine Sales By 50%? – Motley Fool
Probably not in the way some might think.
Fifteen billion dollars: That’s how much Pfizer(NYSE:PFE)projected last month in its Q4 update that it will make this year from its COVID-19 vaccine, BNT162b2. Sure, the company splits profits equally with its partner, BioNTech(NASDAQ:BNTX), but we’re still talking about a lot of money.
The actual amount will almost surely be even higher. Since Pfizer’s update, the U.S. government has ordered another 100 million doses of BNT162b2. But could Pfizer’s revenue from the vaccine be 50% higher because…
-
Noosa News23 hours agoParkyn this, Parkyn that | Noosa Today
-
Noosa News21 hours agoDog daycare program a TikTok hit for helping disabled find work, friends
-
Noosa News21 hours agoAdvocates highlight sexual violence against older people, with Queensland elder abuse inquiry underway
-
Business19 hours ago3 steps to take to build a $1,000 monthly passive income